Charles Schwab Investment Management Inc Incyte Corp Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Incyte Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,643,067 shares of INCY stock, worth $122 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,643,067
Previous 1,609,220
2.1%
Holding current value
$122 Million
Previous $106 Million
6.69%
% of portfolio
0.02%
Previous 0.02%
Shares
30 transactions
Others Institutions Holding INCY
# of Institutions
666Shares Held
187MCall Options Held
714KPut Options Held
557K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.28 Billion21.76% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.58 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.4MShares$1.51 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA15.3MShares$1.13 Billion0.61% of portfolio
-
State Street Corp Boston, MA10.6MShares$782 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $16.5B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...